.
RT-qPCR. Quantitative RT-PCR was performed with SsoFast-EvaGreen real-time PCR kit
(Bio-Rad). Expression was normalized to the expression of GAPDH. Primer pairs used for RT-PCR are listed in Table 2 .
Immunoprecipitation and Western blot analysis. Cells were lysed with a lysis buffer (20 mM Tris, pH 7.5, 100 Mm NaCl, 0.5% Nonidet P-40, 0.5mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride). 4 g anti-VDR (D-6; Santa Cruz) Antibody was pre-bound for 2 h to protein A agarose beads, then was washed with PBS plus 5% BSA and added to the lysate, followed by overnight immunoprecipitation. Protein A agarose beads were then washed five times with washing buffer Table 3 . CCND2, MYC and CDK4 primers (1) and MYC primers for catenin CHIP assay (2) have been described. For re-ChIP assays, VDR immunocomplexes were eluted by adding 40µl
10mM DTT for 30 min at 37 • C. Supernatants were diluted 1:20 in dilution buffer (150 mM NaCl, 1% Triton X-100, 2mM EDTA and 50 mM Tris-HCl, pH 8), and re-ChIP was performed using anti-c-MYC or anti-MXD1 antibodies, as indicated in the figures.
Comparative analysis of ChIPseq data sets for the VDR and c-MYC. A de novo analysis of
VDR ChIPseq data sets generated in the human lymphoblastoid cell line (LCL) GM10855 [GEO accession number GSM558634; (2)] were compared to a c-MYC ChIPSeq data set generated in LCL GM12878 [GEO accession number GSM754334; (3)]. Peaks in all data sets were called using model-based analysis for ChIP-Seq (MACS) (4) run using default parameters (p-value cutoff 1x10 -5 ). The Venn diagram was generated on the data intersections using cistrome integrative analysis toolbox (5) .
Mathematical Modeling of c-MYC/MXD1 expression and turnover: 1,25D application
dramatically affects the c-MYC and MXD1 steady-state values, and more modestly affects the mRNA synthesis and protein degradation rates. We propose a possible mechanism underlying the change in protein levels using a quantitative analysis.
We modeled the effects of 1,25D signaling on c-MYC and MXD1 expression:
where represents an mRNA level; represents a protein level; is an mRNA synthesis rate;
is a rate of production per mRNA molecule; is the amount of circulating mRNA; and and are degradation rates for mRNA and protein, respectively. The superscript represents control conditions (C) or 1,25D treatment (V). The subscript represents c-MYC or MXD1. We computed the time-dependent solutions by solving the system of linear differential equations:
We determine the parameters in these equations using least squares fits to the data (see Fig.   S9A ). We use the experimentally measured levels of c-MYC mRNA (Fig. 1C ) and MXD1 mRNA ( Fig. 2A) to determine the parameters in Eq. (3) and the experimentally measured degradation rates of c-MYC (Fig. 1G) and MXD1 (Fig. 2C) 
